Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$Vir Biotechnology (VIR.US)$ Reuters· 16:05
Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA Prime Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
Translate
Report
1077 Views
Comment
Sign in to post a comment